December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
October 6, 2021
Rich Preyer and Marilyn Jacobs Preyer of Hillsborough, North Carolina, have donated $1 million to support the latest phase of UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study.
September 29, 2021
Chemtai Mungo, MD, MPH, has been appointed as a UNC WRHR Scholar. Her primary research is focused on increasing access to cervical cancer prevention in low-income countries.
September 23, 2021
Hongwei Du, PhD, and Gianpietro Dotti, MD, published research in Nature Cancer showing that a dual-threat CAR-T immunotherapy was effective in animal models of neuroblastoma, a nerve cell cancer.
September 14, 2021
The UNC Lineberger Developmental Funding Program supports the development of cancer research led by faculty to stimulate new applications for extramural funding. All UNC Lineberger Comprehensive Cancer Center members, UNC-Chapel Hill faculty, and UNC system school faculty are encouraged to apply. Available targeted RFAs for the Fall 2021 cycle: (1) Cancer Survivorship Research, (2) Cancer Screening, (3) Population Sciences Approach to Addressing Cancer Disparities in North Carolina
August 4, 2021
Tonia Poteat, PhD, MPH, a core member of the Center for Health Equity Research, and colleagues published research on delays in breast cancer care by race and sexual orientation.
July 12, 2021
Lisa Carey, MD, member of the UNC Lineberger Comprehensive Cancer Center, discusses the clinical implications of the phase 3 FeDeriCa trial in HER2-positive breast cancer.
February 9, 2021
Dr. Rumey Ishizawar, Medical Director of the UNC Rheumatology Clinic, founded the multi-disciplinary UNC Immuno-Oncology Group (IOG) in 2017 to optimize clinical management of cancer patients who develop immune related adverse events (irAEs).
February 3, 2021
Gynecologic Cancers: A Team Approach to Women’s Health Care. Please join the UNC Lineberger Cancer Network for the NC Community College lecture with Daniel Clarke-Pearson, MD, and Lyn Filip, RN, BSN, OCN. More information and registration at unccn.org/02172021
January 28, 2021
Linda Kelly, a 66-year-old mother of four daughters, was diagnosed with breast cancer 20 years ago and received treatment that included a mastectomy and radiation. The medical intervention saved her life but led to some later complications that forced her to seek additional care. COVID-19 almost brought a complete stop to Linda's medical care but after meeting with doctors at UNC, they immediately admitted her and started her on the road to recovery.
October 15, 2020
Expertscape, an online database that assesses and ranks the expertise and contributions of physicians and medical institutions worldwide, ranked Lisa Carey, MD, as one of the top 10 breast cancer experts in the country. Based at the UNC Medical Center, Dr. Carey is the only physician ranked in North Carolina.
October 1, 2020
New research by scientists at UNC Lineberger Comprehensive Cancer Center and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer. The UNC work was led by Chad Pecot, MD, and Emily Harrison, PhD.